Therefore, the cohort of C9orf72 expansion-negative ALS patients from the same geographical area of COVID-19 patients can be considered as representative of the population of that region regarding the genetic background relative to the C9orf72 gene and used to compare COVID-19 patients. This evidence concerns the gene C9orf72 and COVID-19.